Q2 EPS Forecast for Sage Therapeutics Increased by Analyst
Sage Therapeutics, Inc. (NASDAQ:SAGE – Free Report) – Stock analysts at HC Wainwright increased their Q2 2025 earnings estimates for Sage Therapeutics in a research note issued on Wednesday, April 30th. HC Wainwright analyst D. Tsao now forecasts that the biopharmaceutical company will earn ($0.94) per share for the quarter, up from their previous estimate […]
Sage Therapeutics, Inc. (NASDAQ:SAGE – Free Report) – Stock analysts at HC Wainwright increased their Q2 2025 earnings estimates for Sage Therapeutics in a research note issued on Wednesday, April 30th. HC Wainwright analyst D. Tsao now forecasts that the biopharmaceutical company will earn ($0.94) per share for the quarter, up from their previous estimate […]
